Alcan Global Pharmaceutical Packaging, Inc., a prominent player in the pharmaceutical packaging industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in providing innovative packaging solutions tailored for the pharmaceutical sector. With a strong operational presence across North America and Europe, Alcan Global focuses on delivering high-quality, compliant packaging that ensures product integrity and safety. The company’s core offerings include blister packaging, bottles, and flexible packaging solutions, all designed to meet stringent regulatory standards. Alcan Global's commitment to sustainability and advanced technology sets it apart in a competitive market. Recognised for its exceptional quality and customer service, Alcan Global Pharmaceutical Packaging continues to achieve significant milestones, solidifying its position as a trusted partner for pharmaceutical manufacturers worldwide.
How does Alcan Global Pharmaceutical Packaging, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Alcan Global Pharmaceutical Packaging, Inc.'s score of 23 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Alcan Global Pharmaceutical Packaging, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of DWK Life Sciences GmbH, which may influence its climate commitments and initiatives. While there are no documented reduction targets or specific climate pledges from Alcan Global Pharmaceutical Packaging, it is important to note that the parent company, DWK Life Sciences GmbH, may have established sustainability goals and initiatives that could impact Alcan's environmental strategies. However, details on these initiatives are not provided in the available data. As a subsidiary, Alcan's climate commitments may align with those of DWK Life Sciences GmbH, particularly in relation to emissions reduction strategies and sustainability practices. The absence of specific emissions data and reduction targets suggests that Alcan is in the early stages of formalising its climate action plans. In summary, while Alcan Global Pharmaceutical Packaging, Inc. does not currently report specific emissions figures or reduction targets, its relationship with DWK Life Sciences GmbH may provide a framework for future climate commitments and initiatives.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alcan Global Pharmaceutical Packaging, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.